Recently, Duan et al. reported that LSEC senescence could promote steatosis by inactivating pericentral endothelium-derived C-Kit; while infusing C-Kit+-LSECs into aged NASH mice could counteract senescence and steatosis [22]. The gene discussed is KIT; the disease is metabolic dysfunction-associated steatohepatitis.